ST. LOUIS, Aug. 04, 2020 (GLOBE NEWSWIRE) — Aegion Corporation (NASDAQ:AEGN) today announced that its subsidiary, Insituform Technologies, LLC, has […]
Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trialsPowered by T-cell […]